Zuprevo 180 mg/ml is licensed for the treatment and prevention of bovine respiratory disease (BRD) associated with M. haemolytica, P. multocida and H.somni sensitive to tildipirosin.
Zuprevo contains the active tildipirosin - a 16-membered tribasic macrolide antibiotic unique to MSD Animal Health.
Zuprevo offers `real world` benefits - the 180 mg/ml easily syringed solution for injection specifically developed for cattle, delivers a fast and long acting macrolide in a small dose volume.
Dosage: Subcutaneous use.
Administer 4 mg tildipirosin/kg body weight (equivalent to 1 ml/45 kg body weight) once only.
For treatment of cattle over 450 kg body weight, divide the dose so that no more than 10 ml are injected at one site
Legal Category: POM-V
Withdrawal Period: Cattle (Meat and offal): 47 days
Contra Indications: Do not use in case of hypersensitivity to macrolide antibiotics or to any of the excipients.
